Table 1.
Patient and tumor characteristics
| Retrospective 1980–2010 | Prospective 2010–2015 | |
|---|---|---|
| n (%) | n (%) | |
| No of patients | 157 | 292 |
| Gender | ||
| Male | 100 (64) | 168 (57) |
| Female | 57 (36) | 124 (43) |
| Age (years) | ||
| Median (range) | 37 (18–86) | 55 (18–99) |
| 18–25 | 43 (27) | 60 (21) |
| >25 | 114 (73) | 232 (79) |
| Disease spread | ||
| Localized | 111 (71) | 204 (70) |
| Advanced: | 46 (29) | 74 (30) |
| N+M− | 15 | NR |
| N−M+ | 22 | NR |
| N+M+ | 9 | NR |
| Histology | ||
| E‐RMS | 33 (21) | 49 (17) |
| A‐RMS | 55 (35) | 54 (18) |
| P‐RMS | 69 (44) | 189 (65) |
| Site of origin | ||
| Limbs | 76 (48) | 111 (38) |
| Head and Neck | 39 (25) | 65 (22) |
| Parameningeal | 31 | NR |
| No parameningeal | 8 | NR |
| Genitourinary | 14 (9) | NR |
| Vesicoprostatic | 6 | NR |
| No vesicoprostatic | 8 | NR |
| Others | 28 (18) | 116 (40) |
| Size (cm) | ||
| Median (range) | 8 (1–56) | 8 (1–25) |
| <5 | 31 (20) | 74 (25) |
| ≥5 | 103 (66) | 177 (61) |
| NA | 23 (14) | 41 (14) |
N, nodes; M, metastases; E‐RMS, embryonal rhabdomyosarcoma; A‐RMS, alveolar rhabdomyosarcoma; P‐RMS, “adult‐type” rhabdomyosarcoma.